Executive Summary of the American Radium Society Appropriate Use Criteria for Selective Use of Pelvic Radiation Therapy in Locally Advanced Rectal Cancer: A Consensus Statement

Read full text Summarise with VIRAT
Authors: Leila T. Tchelebi, Krishan R. Jethwa, Eric J Dozios, Zhaohui Jin, Gwen Wilson, Christopher James Anker, Gerard J. Abood, Dmitriy G. Akselrod, Joseph Attallah, Don Chamil Codipilly, Christopher Leigh Hallemeier, Timothy J. Kennedy
+7 more Percy P. Lee, Diane C. Ling, Eric David Miller, Neil Bryan Newman, Navesh K. Sharma, William C. Small, Suzanne M. Russo
Cited by: 0
References: 38

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pelvic radiotherapy is commonly incorporated in the treatment of locally-advanced rectal cancer to reduce the risk of locoregional recurrence, but can be associated with substantial acute toxicity and long-term morbidity. However, treatment may be personalized for selective use of radiotherapy in a subset of patients identified to be at low to intermediate risk of locoregional recurrence following resection. This multi-specialty-led committee included gastrointestinal radiation and medical oncology, gastroenterology, radiology, and colorectal surgery. Using the Population, Intervention, Comparator, Outcome, Timing and Study Design (PICOTS) framework, evidence regarding treatment outcomes was assessed using Cochrane and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. Eligible studies included prospective and retrospective (n ≥ 50) studies published between 1/1/2005 - 6/24/2025 from Embase, Medline and PubMed databases. Study type and quality were assessed. Well-established RAND corportaion/University of California Los Angeles (RAND-UCLA) consensus methodology (modified Delphi) was used to rate the appropriateness of the treatment options. Of the 110 articles identified using the search strategy, 35 were selected that met all inclusion criteria. Of the 35 references used as evidence, 35 are categorized as therapeutic including 14 well-designed studies (Phase II randomized and Phase III), 12 moderately well-designed studies that account for most common biases (matched cohort and Phase II studies), 7 studies with design limitations (retrospective reviews), and 3 meta-analyses. Variant cases were developed as examples to illustrate practical applications of consensus recommendations for when RT can be safely omitted. A treatment algorithm is also provided to assist with treatment decisions when considering selective use of pelvic RT.

Fields of Study & Subjects

Colorectal Cancer Surgical Treatments Colorectal and Anal Carcinomas Prostate Cancer Diagnosis and Treatment

Publication details

Journal / source
International Journal of Radiation Oncology*Biology*Physics
Volume
126
Issue
2
Pages
405–414
Publication date
26 March 2026
Language
EN